Claritev (CTEV) Q2 FY26 earnings call

Claritev reported a strong Q2 FY26, exceeding expectations across key financial metrics, driven by robust bookings momentum and effective execution of its vertical market strategy. The company raised its full-year revenue and adjusted EBITDA guidance, signaling confidence in its turnaround journey and sustained growth. Investments in technology modernization and AI are positioning Claritev for future operating leverage and market opportunities, particularly in the evolving healthcare landscape.